Skip to content
evidenceevidencedocumentFederal Criminal TrialA 2013 document to the FDA describing Theranos's two-phase Walgreens approach and use of conventional commercial analyzersDescribes Theranos's two-phase Walgreens approach and its use of conventional commercial analyzers in a 2013 document to the FDA.← All Evidence
Documents & Records

A 2013 document to the FDA describing Theranos's two-phase Walgreens approach and use of conventional commercial analyzers

Describes Theranos's two-phase Walgreens approach and its use of conventional commercial analyzers in a 2013 document to the FDA.

A 2013 document to the FDA describing Theranos's two-phase Walgreens approach and use of conventional commercial analyzers
1 mention

Mentions (1)

FederalFederal Criminal TrialAug 31, 2021 – Jan 3, 2022